Literature DB >> 9775187

[A metastatic neuroendocrine tumor with exceptional outcome!].

C Agard1, P Guerzider, J Bouillard, P Déguiral, M F Nomballais, G Caillé.   

Abstract

INTRODUCTION: Neuroendocrine tumors are rare, with poor prognosis when not or poorly differentiated. EXEGESIS: The authors report the case of a patient who presented with a metastatic poorly differentiated neuroendocrine tumor that was resistant to chemotherapy. The different sites of the carcinoma were lung, pancreas, kidney and lymph nodes. The patient received no treatment and complete spontaneous remission appeared after 21 months. This remission has been lasting for five years.
CONCLUSION: It is the first case of spontaneous remission of a metastatic poorly differentiated neuroendocrine tumor. The evolution and classical sites of neuroendocrine tumors are reviewed. Renal metastasis is also unusual. This report illustrates the fact that neuroendocrine tumors are heterogeneous.

Entities:  

Mesh:

Year:  1998        PMID: 9775187     DOI: 10.1016/s0248-8663(98)80870-9

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  2 in total

Review 1.  Somatostatin analog therapy in treatment of gastrointestinal disorders and tumors.

Authors:  Wouter W de Herder; Steven W J Lamberts
Journal:  Endocrine       Date:  2003-04       Impact factor: 3.633

2.  Assessment of tumor growth in pancreatic neuroendocrine tumors in von Hippel Lindau syndrome.

Authors:  Allison B Weisbrod; Mio Kitano; Francine Thomas; David Williams; Neelam Gulati; Krisana Gesuwan; Yixun Liu; David Venzon; Ismail Turkbey; Peter Choyke; Jack Yao; Steven K Libutti; Naris Nilubol; William M Linehan; Electron Kebebew
Journal:  J Am Coll Surg       Date:  2013-11-12       Impact factor: 6.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.